132 related articles for article (PubMed ID: 8350959)
1. Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer.
Konjević G; Spuzić I
Neoplasma; 1993; 40(2):81-5. PubMed ID: 8350959
[TBL] [Abstract][Full Text] [Related]
2. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of different effects of sera of breast cancer patients on the activity of natural killer cells.
Konjević G; Spuzić I
J Clin Lab Immunol; 1992; 38(2):83-93. PubMed ID: 1343351
[TBL] [Abstract][Full Text] [Related]
4. [Functional activity of the natural killers and macrophages in patients with breast tumors].
Andrianov IG; Voronov SM; Dobkin AN; Okulov VB; Orlov AB
Vopr Onkol; 1988; 34(12):1455-60. PubMed ID: 3265236
[TBL] [Abstract][Full Text] [Related]
5. [The possibilities of modulation of NK cell activity].
Konjević G; Spuzić I
Glas Srp Akad Nauka Med; 2002; (47):89-101. PubMed ID: 16078444
[TBL] [Abstract][Full Text] [Related]
6. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
[TBL] [Abstract][Full Text] [Related]
7. [The effect of serum on NK cell activity].
Konjević G; Spuzić I
Glas Srp Akad Nauka Med; 1991; (41):113-20. PubMed ID: 1916438
[TBL] [Abstract][Full Text] [Related]
8. Decreased response to interleukin-2 of cancer patients in terms of augmentation of natural killer cell activity.
Abe Y; Ajitsu S; Hamuro J; Ishikawa M; Sendo F
Jpn J Cancer Res; 1985 Oct; 76(10):1003-7. PubMed ID: 3935618
[TBL] [Abstract][Full Text] [Related]
9. [The significance of determination of NK cell activity in malignant diseases].
Spuzić I; Konjević G
Glas Srp Akad Nauka Med; 1990; (39):153-60. PubMed ID: 2130019
[TBL] [Abstract][Full Text] [Related]
10. Assessment of host immune response in breast cancer patients.
Akimoto M; Ishii H; Nakajima Y; Iwasaki H; Tan M; Abe R; Kasai M
Cancer Detect Prev; 1986; 9(3-4):311-7. PubMed ID: 3488806
[TBL] [Abstract][Full Text] [Related]
11. Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period.
Lister J; Rybka WB; Donnenberg AD; deMagalhaes-Silverman M; Pincus SM; Bloom EJ; Elder EM; Ball ED; Whiteside TL
Clin Cancer Res; 1995 Jun; 1(6):607-14. PubMed ID: 9816022
[TBL] [Abstract][Full Text] [Related]
12. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
[TBL] [Abstract][Full Text] [Related]
13. [Immunomodulatory effect of serum on NK cells in vitro in healthy individuals].
Konjević G; Spuzić I
Glas Srp Akad Nauka Med; 1994; (44):45-54. PubMed ID: 7590414
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.
Martin-Kleiner I; Gabrilovac J
Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):37-57. PubMed ID: 8683038
[TBL] [Abstract][Full Text] [Related]
16. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients.
Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL
Thymus; 1997; 24(3):147-56. PubMed ID: 9151380
[TBL] [Abstract][Full Text] [Related]
17. Natural killer (NK) cell activity of women with gross cystic disease is inhibited in vitro by breast cyst fluid.
Ardizzoja M; Masera RG; Tacconis P; Sartori ML; Arisio R; Massobrio M; Angeli A
Anticancer Res; 1994; 14(2A):555-9. PubMed ID: 8017860
[TBL] [Abstract][Full Text] [Related]
18. [Immunomodulating activity of natural killers in patients with breast tumors using vasopressin and interleukin 2 in vitro].
Andrianov IG; Dobkin AN; Kiselev OI; Okulov VB; Semiglazov VF
Vopr Onkol; 1989; 35(10):1186-91. PubMed ID: 2596062
[TBL] [Abstract][Full Text] [Related]
19. Immune responses to guided imagery during breast cancer treatment.
Lengacher CA; Bennett MP; Gonzalez L; Gilvary D; Cox CE; Cantor A; Jacobsen PB; Yang C; Djeu J
Biol Res Nurs; 2008 Jan; 9(3):205-14. PubMed ID: 18077773
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell activity and distant metastasis in rectal cancers treated surgically with and without neoadjuvant chemoradiotherapy.
Koda K; Saito N; Oda K; Seike K; Kondo E; Ishizuka M; Takiguchi N; Miyazaki M
J Am Coll Surg; 2003 Aug; 197(2):254-60. PubMed ID: 12892809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]